The latest closing stock price for Foghorn Therapeutics as of September 18, 2024 is 9.56.
An investor who bought $1,000 worth of Foghorn Therapeutics stock at the IPO in 2020 would have $-472 today, roughly 0 times their original investment - a -14.77% compound annual growth rate over 4 years.
The all-time high Foghorn Therapeutics stock closing price was 25.88 on December 18, 2020.
The Foghorn Therapeutics 52-week high stock price is 10.25, which is 7.2% above the current share price.
The Foghorn Therapeutics 52-week low stock price is 2.70, which is 71.8% below the current share price.
The average Foghorn Therapeutics stock price for the last 52 weeks is 5.65.
An investor who bought $1,000 worth of Foghorn Therapeutics stock at the IPO in 2020 would have $-472 today, roughly 0 times their original investment - a -14.77% compound annual growth rate over 4 years.
The all-time high Foghorn Therapeutics stock closing price was 25.88 on December 18, 2020.
The Foghorn Therapeutics 52-week high stock price is 10.25, which is 7.2% above the current share price.
The Foghorn Therapeutics 52-week low stock price is 2.70, which is 71.8% below the current share price.
The average Foghorn Therapeutics stock price for the last 52 weeks is 5.65.